Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed...

Area of Science:

• Biotechnology
• Nanotechnology
• Molecular Biology

Background:

• Exosomes, small extracellular vesicles (30-100 nm), are implicated as disease biomarkers.
• Current diagnostic methods for exosomes require large amounts of purified vesicles, limiting their clinical utility.
• Objective, high-throughput methods are needed to define exosome phenotype and concentration.

Purpose of the Study:

• To develop a sensitive, high-throughput Extracellular Vesicle (EV) Array for exosome detection and phenotyping.
• To analyze exosomes from unpurified biological samples, reducing the need for extensive purification.
• To evaluate the utility of tetraspanin markers (CD9, CD63, CD81) for exosome identification.

Main Methods:

• Protein microarray technology was adapted to create a sensitive EV Array.
• A cocktail of antibodies against CD9, CD63, and CD81 was used to capture and detect exosomes.
• The array was tested for sensitivity using exosomes from a colon cancer cell line and for phenotyping using human plasma.

Main Results:

• The EV Array demonstrated high sensitivity, requiring only ~10^4 cells or 2.5x10^4 exosomes per spot.
• Phenotyping of plasma-derived exosomes revealed significant heterogeneity in surface marker expression among healthy donors.
• CD9 and CD81 showed consistent expression, while CD63 levels varied considerably, questioning its role as a universal exosome marker.

Conclusions:

• The developed EV Array is a sensitive and high-throughput tool for exosome detection and phenotyping from unpurified samples.
• Exosome marker expression is heterogeneous, suggesting a need for careful marker selection in diagnostic applications.
• This technology has the potential to advance exosome-based diagnostics and research.